MEDICAL PROFESSIONALS
Audiovisual Stimulation Technology
The Sana device is a wearable neuromodulation device that delivers a patented sequence of Audiovisual Stimulation (AVS). AVS is a form of neurofeedback and a non-pharmacological intervention that affects the central nervous system by synchronizing groups of neurons to frequencies of light and sound presented to the eyes and ears of the users.
When the brain is given a stimulus through the eyes and ears it emits a responsive electrical charge, called a Cortical Evoked Response (CER). These electrical responses measured via electrodes, travel throughout the brain and are ultimately perceived as vision and audible sound. When the input stimulus resembles a pattern the brain itself uses, the brain responds by synchronizing to it, a process called Frequency Following Response (FFR). The brain follows a complex series of electrical patterns every time it goes into healthy relaxation. Frequency Following Response can be used to trigger each electrical pattern, in turn, to put the brain into a restful, healthy state of relaxation.
Sana Personalized Neuromodulation
The Sana device uses a complex proprietary pattern of light and sound impulses to restore a balance in brain wave patterns.
The Sana device leverages these electrical patterns that resemble the effect of long-term meditative practices by encouraging the brain to synchronize and balance the energy across hemispheres, leading to a restful state of mind.
Sana’s Focus on Clinical Evidence
Pilot Fibromyalgia Clinical Study
Objective: The Pilot Fibromyalgia Clinical Study was a single-arm 20-person trial in which patients who had failed to find adequate relief from traditional treatments were given the Sana device to use two+ times a day for two weeks.
Results: The participants in this study reduced their perception of pain by 20% (p=0.002) as well as reducing their ratings of anxiety by 36% (p=0.0054). In addition, 84% of participants had a reduction in pain and 85% of participants chose to continue using the Sana device after the study.
Opioid Dependency Clinical Study
Objective: The Opioid Dependence Study was a double-blind Active vs. Sham crossover trial that examined the improvement in withdrawal symptom management after the use of the Sana device versus sham.
Results: These figures show that participants in this trial reduced their subjective perception of opioid withdrawal (SOWS) by 36% on average as well as their anxiety ratings 36% to 45% on average.
Recovery User Experience Study
Objective: The Recovery Study was a parallel arm double-blind comparison of Active vs. Sham on performance, fatigue, and pain measures of healthy adults during a 24-hour period of sleep deprivation.
Results: The chart shows that participants who received the Sana device had a statistically trending average increase in reaction time on the Psychomotor Vigilance Test (PVT) of 94ms over the sham device (p = 0.06). This result suggests that following the use of the Sana device a strong state of relaxation is experienced by participants that is demonstrated by slower reaction times.